ArticleBMC musculoskeletal disorders2025
Comparison of clinical outcomes of trochanteric femoral nail advanced system (TFNA) with and without cement augmentation for geriatric unstable trochanteric fractures: a single-center retrospective cohort study.
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [Cement augmentation in pertrochanteric fractures : Evidence, indication and surgical application].Unfallchirurgie (Heidelberg, Germany) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionUnstable trochanteric fractures (AO types A2 or A3) are reported to be risk factors for mechanical failure such as screw cut-out. This study aimed to compare the incidence of implant related complications and functional outcomes between cement augmentation and non-augmentation.
methodsPatients at a single institution aged > 60 years who underwent fixation using the trochanteric femoral nail advanced system (TFNA) with or without cement augmentation from 2020 to 2023 were retrospectively analyzed. We evaluated reduction quality and screw position on immediate postoperative radiographs, the occurrence of screw cut-out, and Parker's mobility score (PMS) as functional outcomes.
resultsWe evaluated 140 patients in the non-augmentation group and 93 patients in the augmentation group. The mean follow-up period was 13.6 ± 5.7 months. The mean age was 86.0 ± 8.1 years in the non-augmentation and 85.2 ± 8.3 years in the cement augmentation group. Patient demographics, including fracture type, were similar in both groups. The screw cut-out rate was seven out of 140 patients (5.0%) in the non-augmentation group, whereas no patients in the augmentation group experienced screw cut-out, and the difference was significant (p = 0.044). All cases which occurred screw cut-out were associated with postoperative poor reduction quality and screw malposition. The mean PMS at the last follow-up was 4.0 ± 3.0 in the non-augmentation group and 4.7 ± 2.7 in the augmentation group, and the difference was not significant (p = 0.187).
conclusionsCement augmentation showed a significant lower screw cut-out rate compared with non-augmentation. This technique could be a more favorable option for osteoporotic unstable trochanteric fractures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.